{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:25:12Z","timestamp":1795040712128,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"La Caixa","award":["LCF\/PR\/GN17\/50300004"],"award-info":[{"award-number":["LCF\/PR\/GN17\/50300004"]}]},{"name":"TriBEKa Imaging Platform Project","award":["TriBEKa-17-519007"],"award-info":[{"award-number":["TriBEKa-17-519007"]}]},{"name":"Health Research and Innovation Strategic Plan","award":["SLT002\/16\/00201"],"award-info":[{"award-number":["SLT002\/16\/00201"]}]},{"name":"Ministry of Business and Knowledge of the Catalan Government","award":["2017-SGR-892"],"award-info":[{"award-number":["2017-SGR-892"]}]},{"name":"Juan de la Cierva Programme","award":["FJC2018-038085-I"],"award-info":[{"award-number":["FJC2018-038085-I"]}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["752310"],"award-info":[{"award-number":["752310"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00155"],"award-info":[{"award-number":["PI19\/00155"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Juan de la Cierva Programme Grant","award":["IJC2018-037478-I"],"award-info":[{"award-number":["IJC2018-037478-I"]}]},{"name":"Spanish Ministry of Science","award":["RYC2018-026053-I"],"award-info":[{"award-number":["RYC2018-026053-I"]}]},{"name":"Spanish Ministry of Science","award":["FJCI-2017-33437"],"award-info":[{"award-number":["FJCI-2017-33437"]}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["RYC-2013-13054"],"award-info":[{"award-number":["RYC-2013-13054"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2017-00915"],"award-info":[{"award-number":["#2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["RDAPB-201809-2016615"],"award-info":[{"award-number":["RDAPB-201809-2016615"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Alzheimer Foundation","award":["AF-742881"],"award-info":[{"award-number":["AF-742881"]}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2017-0243"],"award-info":[{"award-number":["FO2017-0243"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF-agreement","award":["ALFGBG-715986"],"award-info":[{"award-number":["ALFGBG-715986"]}]},{"name":"ALF-agreement","award":["ALFGBG-720931"],"award-info":[{"award-number":["ALFGBG-720931"]}]},{"name":"European Union Joint Program for Neurodegenerative Disorders","award":["JPND2019-466-236"],"award-info":[{"award-number":["JPND2019-466-236"]}]},{"name":"European Research Council","award":["681712"],"award-info":[{"award-number":["681712"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Perivascular spaces (PVS) have an important role in the elimination of metabolic waste from the brain. It has been hypothesized that the enlargement of PVS (ePVS) could be affected by pathophysiological mechanisms involved in Alzheimer\u2019s disease (AD), such as abnormal levels of CSF biomarkers. However, the relationship between ePVS and these pathophysiological mechanisms remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We aimed to investigate the association between ePVS and CSF biomarkers of several pathophysiological mechanisms for AD. We hypothesized that ePVS will be associated to CSF biomarkers early in the AD continuum (i.e., amyloid positive cognitively unimpaired individuals). Besides, we explored associations between ePVS and demographic and cardiovascular risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 322 middle-aged cognitively unimpaired participants from the ALFA\u2009+\u2009study, many within the Alzheimer\u2019s <jats:italic>continuum<\/jats:italic>. NeuroToolKit and Elecsys\u00ae immunoassays were used to measure CSF A\u03b242, A\u03b240, p-tau and t-tau, NfL, neurogranin, TREM2, YKL40, GFAP, IL6, S100, and \u03b1-synuclein. PVS in the basal ganglia (BG) and centrum semiovale (CS) were assessed based on a validated 4-point visual rating scale. Odds ratios were calculated for associations of cardiovascular and AD risk factors with ePVS using logistic and multinomial models adjusted for relevant confounders. Models were stratified by A\u03b2 status (positivity defined as A\u03b242\/40\u2009&lt;\u20090.071).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The degree of PVS significantly increased with age in both, BG and CS regions independently of cardiovascular risk factors. Higher levels of p-tau, t-tau, and neurogranin were significantly associated with ePVS in the CS of A\u03b2 positive individuals, after accounting for relevant confounders. No associations were detected in the BG neither in A\u03b2 negative participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results support that ePVS in the CS are specifically associated with tau pathophysiology, neurodegeneration, and synaptic dysfunction in asymptomatic stages of the Alzheimer\u2019s <jats:italic>continuum<\/jats:italic>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00878-5","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:02:51Z","timestamp":1628146971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer\u2019s continuum"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-6721","authenticated-orcid":false,"given":"Natalia","family":"Vilor-Tejedor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Ciampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Crous-Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider M.","family":"Arenaza-Urquijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mil\u00e0-Alom\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderic","family":"Guigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-6001","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-0642","authenticated-orcid":false,"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ALFA study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Beteta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brugulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Deulofeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cumplido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Emilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Fauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Huesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mench\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pradas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rodriguez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Sala-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Soteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"878_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jon.12493","volume":"28","author":"JD Rudie","year":"2018","unstructured":"Rudie JD, Rauschecker AM, Nabavizadeh SA, Mohan S. Neuroimaging of dilated perivascular spaces: from benign and pathologic causes to mimics. J Neuroimaging. 2018;28:139\u201349.","journal-title":"J Neuroimaging"},{"key":"878_CR2","doi-asserted-by":"publisher","DOI":"10.1148\/rg.274065722","author":"RM Kwee","year":"2007","unstructured":"Kwee RM, Kwee TC. Virchow-Robin spaces at MR imaging. Radiographics. 2007. https:\/\/doi.org\/10.1148\/rg.274065722.","journal-title":"Radiographics"},{"key":"878_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4103\/2152-7806.192486","volume":"7","author":"I Cherian","year":"2016","unstructured":"Cherian I, et al. Exploring the Virchow-Robin spaces function: a unified theory of brain diseases. Surg Neurol Int. 2016;7:711.","journal-title":"Surg Neurol Int"},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaneurol.2017.1397","volume":"74","author":"J Ding","year":"2017","unstructured":"Ding J, et al. Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia. JAMA Neurol. 2017;74:1105.","journal-title":"JAMA Neurol"},{"key":"878_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamaneurol.2018.3122","volume":"76","author":"S Debette","year":"2019","unstructured":"Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76:81\u201394.","journal-title":"JAMA Neurol"},{"key":"878_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1747493019830321","volume":"14","author":"F Francis","year":"2019","unstructured":"Francis F, Ballerini L, Wardlaw JM. Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis. Int J Stroke. 2019;14:359\u201371.","journal-title":"Int J Stroke"},{"key":"878_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","volume":"16","author":"JM Wardlaw","year":"2020","unstructured":"Wardlaw JM, et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol. 2020;16:137\u201353.","journal-title":"Nat Rev Neurol"},{"key":"878_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70124-8","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology. 2013. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8.","journal-title":"The Lancet Neurology"},{"key":"878_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bpa.12218","volume":"25","author":"RO Weller","year":"2015","unstructured":"Weller RO, Hawkes CA, Kalaria RN, Werring DJ, Carare RO. White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol. 2015;25:63\u201378.","journal-title":"Brain Pathol"},{"key":"878_CR10","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/brain\/awn171","volume":"131","author":"J Wuerfel","year":"2008","unstructured":"Wuerfel J, et al. Perivascular spaces\u2013MRI marker of inflammatory activity in the brain? Brain. 2008;131:2332\u201340.","journal-title":"Brain"},{"key":"878_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2012-120874","volume":"33","author":"CL Satizabal","year":"2012","unstructured":"Satizabal CL, Zhu Y-C, Dufouil C, Tzourio C. Inflammatory proteins and the severity of dilated Virchow-Robin spaces in the elderly. J Alzheimer\u2019s Dis. 2012;33:323\u20138.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"878_CR12","doi-asserted-by":"publisher","unstructured":"Mil\u00e0-Alom\u00e0, M. et al. Amyloid-\u03b2, tau, synaptic, neurodegeneration and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimer\u2019s % Dement. (2020) doi:https:\/\/doi.org\/10.1002\/ALZ.12131.","DOI":"10.1002\/ALZ.12131"},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s and Dementia. 2018;14:535\u201362.","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"878_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","volume":"2","author":"JL Molinuevo","year":"2016","unstructured":"Molinuevo JL, et al. The ALFA project: A research platform to identify early pathophysiological features of Alzheimer\u2019s disease. Alzheimer\u2019s Dement Transl Res Clin Interv. 2016;2:82\u201392.","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"878_CR15","unstructured":"Schmidt, P. Bayesian inference for structured additive regression models for large-scale problems with applications to medical imaging. (2017)."},{"key":"878_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000375153","volume":"39","author":"GM Potter","year":"2015","unstructured":"Potter GM, Chappell FM, Morris Z, Wardlaw JM. Cerebral perivascular spaces visible on magnetic resonance imaging: Development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis. 2015;39:224\u201331.","journal-title":"Cerebrovasc Dis"},{"key":"878_CR17","doi-asserted-by":"crossref","unstructured":"Mil\u00e0-Alom\u00e0, Marta; Salvad\u00f3, Gemma; Shekari, M. et al. Comparative Analysis of Different Definitions of Amyloid-\u03b2 Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer. J. Prev. Alzheimer\u2019s Dis. in press, (2020).","DOI":"10.14283\/jpad.2020.51"},{"key":"878_CR18","first-page":"495","volume":"86","author":"AR Comellas","year":"2012","unstructured":"Comellas AR, et al. Validation of a spanish short version of the minnesota leisure time physical activity questionnaire (vrem). Rev Esp Salud Publica. 2012;86:495\u2013508.","journal-title":"Rev Esp Salud Publica"},{"key":"878_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5:735\u201341.","journal-title":"Lancet Neurol"},{"key":"878_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ejhg.2013.308","volume":"22","author":"F Radmanesh","year":"2014","unstructured":"Radmanesh F, et al. Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. Eur J Hum Genet. 2014;22:1239\u201342.","journal-title":"Eur J Hum Genet"},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease. Alzheimer\u2019s Research and Therapy. 2019;11:1\u201315.","journal-title":"Alzheimer\u2019s Research and Therapy"},{"key":"878_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nn.4464","volume":"20","author":"JM Olson","year":"2017","unstructured":"Olson JM, Tongprasearth K, Nitz DA. Subiculum neurons map the current axis of travel. Nat Neurosci. 2017;20:170\u20132.","journal-title":"Nat Neurosci"},{"key":"878_CR23","doi-asserted-by":"crossref","unstructured":"Zhang, C. et al. Risk Factors of Dilated Virchow-Robin Spaces Are Different in Various Brain Regions. PLoS One 9, e105505 (2014).","DOI":"10.1371\/journal.pone.0105505"},{"key":"878_CR24","doi-asserted-by":"crossref","unstructured":"Ballerini, L. et al. Computational quantification of brain perivascular space morphologies: associations with vascular risk factors and white matter hyperintensities. a study in the Lothian Birth Cohort 1936. NeuroImage Clin. 25, 102120 (2020).","DOI":"10.1016\/j.nicl.2019.102120"},{"key":"878_CR25","doi-asserted-by":"crossref","unstructured":"Loos, C. M. J., Klarenbeek, P., Van Oostenbrugge, R. J. & Staals, J. Association between perivascular spaces and progression of white matter hyperintensities in lacunar stroke patients. PLoS One 10, (2015).","DOI":"10.1371\/journal.pone.0137323"},{"key":"878_CR26","unstructured":"Heier, L. A. et al. Large Virchow-Robin Spaces: MR-Clinical Correlation."},{"key":"878_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.591586","author":"YC Zhu","year":"2010","unstructured":"Zhu YC, et al. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke. 2010. https:\/\/doi.org\/10.1161\/STROKEAHA.110.591586.","journal-title":"Stroke"},{"key":"878_CR28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3233\/JAD-180367","volume":"66","author":"EL Boespflug","year":"2018","unstructured":"Boespflug EL, et al. Targeted assessment of enlargement of the perivascular space in Alzheimer\u2019s disease and vascular dementia subtypes implicates astroglial involvement specific to Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;66:1587\u201397.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"878_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, et al. ApoE4 Accelerates early seeding of amyloid pathology. Neuron. 2017;96:1024-1032.e3.","journal-title":"Neuron"},{"key":"878_CR30","doi-asserted-by":"crossref","unstructured":"Laveskog, A. et al. Associations of vascular risk factors and APOE genotype with perivascular spaces among community-dwelling older adults. J. Am. Heart Assoc. 9, e015229 (2020).","DOI":"10.1161\/JAHA.119.015229"},{"key":"878_CR31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17724","author":"X Luo","year":"2017","unstructured":"Luo X, et al. Associations between APOE genotype and cerebral small-vessel disease: A longitudinal study. Oncotarget. 2017. https:\/\/doi.org\/10.18632\/oncotarget.17724.","journal-title":"Oncotarget"},{"key":"878_CR32","doi-asserted-by":"publisher","first-page":"P408","DOI":"10.1016\/j.jalz.2014.05.510","volume":"10","author":"HHH Adams","year":"2014","unstructured":"Adams HHH, et al. Determinants of Enlarged Virchow-Robin Spaces: The UNIVRSE Consortium. Alzheimer\u2019s Dement. 2014;10:P408.","journal-title":"Alzheimer\u2019s Dement"},{"key":"878_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54204-z","volume":"9","author":"K Blennow","year":"2019","unstructured":"Blennow K, et al. Predicting clinical decline and conversion to Alzheimer\u2019s disease or dementia using novel Elecsys A\u03b2(1\u201342), pTau and tTau CSF immunoassays. Sci Rep. 2019;9:1\u201311.","journal-title":"Sci Rep"},{"key":"878_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clinbiochem.2019.05.005","volume":"72","author":"V Lifke","year":"2019","unstructured":"Lifke V, et al. Elecsys\u00ae Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid. Clin Biochem. 2019;72:30\u20138.","journal-title":"Clin Biochem"},{"key":"878_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jalz.2018.01.016","volume":"14","author":"R Cacciaglia","year":"2018","unstructured":"Cacciaglia R, et al. Effects of APOE -\u03b54 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:902\u201312.","journal-title":"Alzheimer\u2019s Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00878-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:07:02Z","timestamp":1628147222000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00878-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the directives of Spanish Law 14\/2007, of 3rd July, on Biomedical Research (Ley 14\/2007 de Investigaci\u00f3n Biom\u00e9dica). Study protocols were approved by the Clinical Research Ethics Committee \u201cParc de Salut Mar\u201d, Barcelona. All participants accepted the study procedures by signing the study\u2019s informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GK is a full-time employee of Roche Diagnostics GmbH. The remaining authors declare that they have no conflict of interest. HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, and CogRx; has given lectures in symposia sponsored by Fujirebio, Alzecure, and Biogen;and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. JLM has served\/serves as a consultant or at advisory boards for the following for-profit companies or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, ProMIS Neurosciences. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD\/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. The other co-authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}